Biotech Startups in North Carolina

5 Biotech companies in North Carolina that have filed with the SEC.

5Companies

Aer Therapeutics, Inc.

Biotechnology
Raleigh, North Carolina

Aer Therapeutics, Inc. is a biopharmaceutical company that specializes in the development of innovative therapies targeting mucus-related issues in lung diseases. The company's primary focus is on creating inhalable treatments to address airway mucus plugs, which are common in conditions like COPD and asthma.

Altis Biosystems, Inc.

Biotechnology
Durham, North Carolina

Altis Biosystems, Inc. is a pioneering biotechnology firm based in North Carolina, dedicated to enhancing preclinical research through the development of innovative human cell-based models that accurately replicate the gastrointestinal (GI) tract. By providing superior alternatives to traditional cell line and animal models, Altis facilitates improved drug discovery and development, ensuring better predictive insights and reducing reliance on animal testing.

BioPhoundry, Inc.

Biotechnology
Chapel Hill, North Carolina

BioPhoundry, Inc. is a pioneering biotechnology company that specializes in the development of advanced bioengineering solutions to address complex biological challenges. They are committed to driving innovation in the biotechnology sector through robust research and cutting-edge technology.

Founded 2024

Scorpius Holdings, Inc.

Biotechnology
Morrisville, North Carolina

Scorpius Holdings, Inc. is a leading contract development and manufacturing organization (CDMO) specializing in biologics manufacturing through its subsidiary, Scorpius BioManufacturing. Based in Morrisville, North Carolina, with facilities in San Antonio, Texas, the company provides comprehensive services including process development and analytical testing to pharmaceutical and biotech companies.

Xilis, Inc.

Biotechnology
Durham, North Carolina

Xilis, Inc. is a biotech company focused on transforming cancer treatment through innovative technologies that enable personalized medicine. By leveraging its proprietary MicroOrganoSphere™ technology, Xilis offers tailored therapeutic solutions that match cancer patients with the most effective treatments based on their individual tumor biology.